Evidence map›Paper›PMID 37899073›Full record

ArticleDigestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society2024

Pilot study on anti-reflux mucoplasty: Advancing endoscopic anti-reflux therapy for gastroesophageal reflux disease.

Haruhiro Inoue, Kazuki Yamamoto, Yuto Shimamura, Daisuke Azuma, Kei Ushikubo, Hiroki Okada, Yoshiaki Kimoto, Yohei Nishikawa, Ippei Tanaka, Mayo Tanabe and 2 more

Abstract read
In one paragraph

Article in Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Phase concept: Novel dynamic endoscopic assessment of intramural antireflux mechanisms (with video).Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society · 2025
    Article
  12. Review
  13. Article
  14. Introducing antireflux mucoplasty with valve: a novel endoscopic treatment for GERD.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2024
    Article
  15. Closure in antireflux mucoplasty using anchor prong clips: dead space-eliminating technique.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2024
    Article
  16. Cap-EMR Ⅱ.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2024
    Article
  17. Enhancing closure efficacy in antireflux mucoplasty through endoscopic hand-suturing technique.VideoGIE : an official video journal of the American Society for Gastrointestinal Endoscopy · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Haruhiro InoueDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Kazuki YamamotoDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0001-6614-2763
Yuto ShimamuraDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0003-4107-9264
Daisuke AzumaDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Kei UshikuboDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Hiroki OkadaDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Yoshiaki KimotoDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0003-4813-342X
Yohei NishikawaDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Ippei TanakaDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0001-8776-6663
Mayo TanabeDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.ORCID https://orcid.org/0000-0001-6126-5684
Manabu OnimaruDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.
Marc Julius NavarroDigestive Diseases Center, Showa University Koto Toyosu Hospital, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesAnti-reflux mucosectomy (ARMS) and anti-reflux mucosal ablation (ARMA) were developed as interventions for proton pump inhibitor (PPI)-refractory/-dependent gastroesophageal reflux disease (GERD). Although ARMS and ARMA are established treatments for PPI-refractory GERD, reliance on natural healing for ulcer scar formation introduces uncertainty and bleeding risk. To address these issues, we introduced a novel approach called anti-reflux mucoplasty (ARM-P), which involves immediate closure of mucosal defects following mucosectomy. This pilot study aims to evaluate the safety, feasibility, and efficacy of ARM-P.

methodsA retrospective single-center study was conducted using prospectively collected data from October 2022 to July 2023. Patients with PPI-refractory/-dependent GERD who underwent ARM-P were included. The study evaluated technical success of ARM-P, before and after ARM-P GERD-Health Related Quality of Life Questionnaire, GerdQ, and Frequency Scale for the Symptoms of GERD scores, along with PPI discontinuation and endoscopic esophagogastric junction morphology.

resultsA total of 20 patients with a median age of 61.5 years underwent the ARM-P procedure. The procedure achieved 100% technical success without adverse events. After ARM-P, 55.0% discontinued PPI usage and 15.0% reduced PPI dose by half. Median GERD-Health Related Quality of Life Questionnaire score improved from 21 to 6 (P = 0.0026), median GerdQ score improved from 9 to 7 (P = 0.0022), and median Frequency Scale for the Symptoms of GERD score decreased from 16 to 7 (P = 0.0003). Median Hill's Classification significantly improved from grade III to grade I (P = 0.0001).

conclusionsThis study presents the first pilot report of ARM-P, demonstrating its procedural safety, technical feasibility, and short-term efficacy.

Indexed as

Gastroesophageal RefluxAdultAgedEndoscopic Mucosal ResectionFeasibility StudiesFemaleHumansMaleMiddle AgedPilot ProjectsProton Pump InhibitorsQuality of LifeRetrospective StudiesTreatment OutcomeProton Pump Inhibitorsanti‐reflux mucoplastyanti‐reflux mucosal ablationanti‐reflux mucosectomyendoscopic anti‐reflux therapygastroesophageal reflux disease

Identifiers

PMID37899073
PMCPMC12108231

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.